In CCM areas, the local production of IL-17 and IFN-γ by Th17.1 cells would activate other local (microglia) and migrant (monocytes and B cells) immune cells, as well as endothelial cells, which increase the tissue damage. This evidence concerns the gene IFNG and cerebral cavernous malformation.